Worldwide Large Molecule Bioanalytical Testing Services Industry to 2029 – Increased Complication of Product Designs and Engineering is Driving Growth – ResearchAndMarkets.com

Worldwide Large Molecule Bioanalytical Testing Services Industry to 2029 – Increased Complication of Product Designs and Engineering is Driving Growth – ResearchAndMarkets.com




Worldwide Large Molecule Bioanalytical Testing Services Industry to 2029 – Increased Complication of Product Designs and Engineering is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Large Molecule Bioanalytical Testing Services Market Analysis by Phase, by Type, by Test Type, by Therapeutic Area, by End user by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The large molecule bioanalytical testing services market size is estimated to be USD 1.7 billion in 2021 and is expected to witness a CAGR of 11.58%% during the forecast period 2022-2029.

The market is expected to grow due to , and rising demands for advanced and high-quality large molecule bioanalytical testing services.

Other factors driving market expansion include increased regulatory supervision and a significant risk of product failure. However, concerns about legality while outsourcing is expected to limit the market growth.

Companies Mentioned

  • Charles River (US)
  • Medpace (US)
  • WuXi AppTec (China)
  • Eurofins Scientific (Luxembourg)
  • IQVIA Inc. (US)
  • SGS SA (Switzerland)
  • Laboratory Corporation of America Holdings (US)
  • Intertek Group plc (UK)
  • PRA Health Sciences (US)
  • Syneos Health (US)
  • ICON plc (Ireland)
  • Frontage Labs (US)
  • PPD Inc. (US)
  • PAREXEL International Corporation (US)
  • Almac Group (UK)
  • Celerion (US)
  • Altasciences (US)
  • BioAgilytix Labs (US)
  • Lotus Labs Pvt. Ltd. (India)
  • LGS Limited (UK)

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including phase, type, test type, therapeutic area, and end user from 2021 to 2029.

Segmentation: Large Molecule Bioanalytical Testing Services Market Report 2021-2029

By Phase (Revenue, USD Billion)

  • Clinical
  • Pre-clinical

By Type (Revenue, USD Billion)

  • ADA
  • Pharmacokinetics
  • Others

By Test Type (Revenue, USD Billion)

  • Bioequivalence
  • Bio availability
  • ADME
  • PD
  • PK
  • Other Tests

By Therapeutic Area (Revenue, USD Billion)

  • Infectious Disease
  • Oncology
  • Neurology
  • Cardiology
  • Others

By End user (Revenue, USD Billion)

  • Large Firms
  • SMEs

By Region (Revenue, USD Billion)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/qcwwb8

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900